This is topic SNGX Soligenix, Inc. in forum .11 and Up! at's Bulletin Board.

To visit this topic, use this URL:

Posted by BooDog on :
Soligenix Enters Q4 With Multiple Catalysts in Play
Newsfile Corp.
Thu, October 13, 2022 at 5:30 AM·4 min read
In this article:

New York, New York--(Newsfile Corp. - October 13, 2022) - PCG Digital -- Late-stage biopharmaceutical company, Soligenix, Inc. (NASDAQ: SNGX) is anticipating significant catalysts in Q4 and a potentially transformational year in 2023. html

Shs Outstand 43.01M

Like the cup & handle. See if it can get back over the $ without a RS.
Posted by Bob Frey on :
Good to see you post.

© 1997 - 2021 All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2